Press Releases CS MEDICA A/S

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
4.901 ^DKK	-2.49%		-8.58%	+4.66%

May. 23	Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024
May. 17	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CS MEDICA receives 2 MDKK to support its short-term financial obligations.	May. 28	AQ
CS MEDICA A/S announces financial results for the first half of the financial year 2023/24	May. 17	AQ
CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed	May. 07	AQ
CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany	Apr. 30	AQ
CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company	Apr. 25	AQ
CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.	Apr. 22	AQ
CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	Apr. 04	AQ
CS MEDICA Update: Rescheduled Q4 2023 Presentation	Apr. 03	AQ
Correction:CS MEDICA A/S: Publication of 2023 Q report	Apr. 02	AQ
CS MEDICA A/S: Release of 2023 Q report, for the period October - December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET.	Mar. 29	AQ
CS MEDICA A/S: Minutes of the General Assembly	Feb. 29	AQ
Letter from the CEO: CS MEDICA's 2024 Progress Report	Feb. 28	AQ
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan	Feb. 20	AQ
CS MEDICA A/S: Notice of Shareholders' Annual General Meeting	Feb. 14	AQ
CS MEDICA A/S: Publication of Annual Report 2022/2023	Feb. 14	AQ
CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment.	Feb. 02	AQ
CS MEDICA Breaks New Ground in Australia with Registration of CANNASEN® Pain Patch and Launch of its Cosmetic Products.	Jan. 26	AQ
Danske Bank Extends CS MEDICA's Credit Line	Jan. 23	AQ
CS MEDICA A/S Announces FDA authorization for commercialization for Eight Products in the U.S. Market	Dec. 27	AQ
CS MEDICA A/S presents the CEO Letter of December 2023	Dec. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CS MEDICA A/S

Equities

CSMED

DK0061668225

Press Releases

Filters